Cargando…
Current and emerging biologic therapies targeting eosinophilic disorders
Eosinophilic disorders include a wide array of conditions in which eosinophils play a primary pathophysiologic role. While historically treated with corticosteroids and immunosuppressants, knowledge of eosinophil biology has led to the development of several biologics targeting eosinophils. In this...
Autores principales: | Pitlick, Mitchell M., Li, James T., Pongdee, Thanai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356173/ https://www.ncbi.nlm.nih.gov/pubmed/35983569 http://dx.doi.org/10.1016/j.waojou.2022.100676 |
Ejemplares similares
-
Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
por: Pitlick, Mitchell M., et al.
Publicado: (2022) -
Risks and safety of biologics: A practical guide for allergists
por: Sitek, Andrea N., et al.
Publicado: (2023) -
404 Allergen Specific Immunotherapy as a Treatment for Eosinophilic Esophagitis
por: Perez, Juan Esteban, et al.
Publicado: (2012) -
Hypersensitivity reactions to biologics used in the treatment of allergic diseases: clinical features, diagnosis and management
por: Sitek, Andrea, et al.
Publicado: (2023) -
316 Botox Injections in Larynx as a Treatment for Vocal Cord Dysfunction
por: Perez, Juan Esteban, et al.
Publicado: (2012)